The London-based investor in life science companies said data from the second-phase trial was positive. Beacon Therapeutics, a Florida, US-based opthalmic gene therapy company, assessed two different ...
(Alliance News) - Shield Therapeutics PLC on Friday said it intends to raise USD10.0 million via a share subscription, and launched a retail offer to raise a further GBP1.0 million.
(Alliance News) - Schroder European Real Estate Investment Trust PLC on Friday reported it had returned to annual profit as loss from fair value adjustment on investment property waned.